Infections, Dental Disease, Sexual Dysfunction, and Other Comorbidities

Infections

Hyperglycemia impairs neutrophil function and microvascular circulation, raising both the risk and the severity of infections in people with diabetes. Common sites include urinary tract infections, which are more frequent and can be more severe, including rare but serious presentations such as emphysematous pyelonephritis; skin and soft-tissue infections; and fungal infections, particularly genital candidiasis, which can be the presenting symptom that leads to an undiagnosed diabetes diagnosis. Foot infections in a neuropathic or ischemic foot can progress rapidly to osteomyelitis and often require aggressive, multidisciplinary management combining antibiotics, debridement, and offloading.

Periodontal and Dental Disease

Periodontal disease is more prevalent and more severe in people with diabetes and has a bidirectional relationship with glycemic control: periodontal inflammation worsens insulin resistance and glycemic control, and poor glycemic control in turn worsens periodontal disease and delays healing after dental treatment. The CDCES should reinforce routine dental care, ask about symptoms such as bleeding gums or loose teeth as part of comprehensive self-care education, and treat oral health as clinically connected to glycemic outcomes rather than as a separate concern, since dental visits are often deprioritized relative to medical visits. General preventive-care advice is professional dental cleanings and exams at least twice yearly, with prompt evaluation of any new bleeding, swelling, or looseness rather than waiting for the next scheduled visit.

Sexual Dysfunction

Erectile dysfunction affects a substantial proportion of men with diabetes and tends to occur earlier and more severely than in the general population, driven by the same vascular and neuropathic mechanisms that underlie other micro- and macrovascular complications; because patients rarely volunteer these symptoms, the CDCES should ask about them directly as part of a comprehensive history. Female sexual dysfunction, including reduced desire, difficulty with arousal, and dyspareunia related to vaginal dryness or recurrent candidiasis, is also more common in women with diabetes and is comparably underscreened in practice. Both are addressed through glycemic optimization, treatment of contributing comorbidities such as vascular disease, neuropathy, or depression, and referral to a specialist when indicated. Structured symptom questionnaires can standardize what is otherwise an easy-to-skip line of questioning during a routine visit, but the essential CDCES skill is simply asking the question rather than waiting for the person to raise it.

Other Comorbidities

Diabetes clusters with several other conditions that change both a person's overall risk profile and the complexity of day-to-day self-management:

• Depression occurs roughly twice as often in people with diabetes as in the general population, worsens self-management behaviors and glycemic outcomes, and warrants routine screening, for example with the PHQ-2 or PHQ-9, as part of comprehensive assessment.
• Thyroid disease, particularly autoimmune thyroid disease such as Hashimoto thyroiditis or Graves disease, co-occurs frequently with type 1 diabetes because of shared autoimmune susceptibility; checking thyroid function at diagnosis and periodically thereafter is reasonable practice.
• Obstructive sleep apnea (OSA) is highly prevalent in type 2 diabetes, especially with coexisting obesity, and worsens both insulin resistance and cardiovascular risk; screening for OSA symptoms should be considered, particularly when hypertension is poorly controlled or hyperglycemia is otherwise unexplained.
• Polycystic ovary syndrome (PCOS) is associated with insulin resistance and a substantially elevated lifetime risk of type 2 diabetes, so women with PCOS warrant periodic glucose screening even before other risk factors appear.
• Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), the current term for what was formerly called NAFLD, are highly prevalent in type 2 diabetes; weight management is first-line therapy, and some glucose-lowering agents, including GLP-1 receptor agonists and pioglitazone, have direct hepatic benefit beyond glycemic control.
• Cognitive decline and dementia risk is increased in people with diabetes, particularly with a history of recurrent severe hypoglycemia; cognitive screening should be considered in older adults, and glycemic targets should be simplified or relaxed when cognitive impairment is present, to reduce the risk of further hypoglycemia.

Putting It Together

None of these comorbidities are screened in isolation, and none of them appear on a routine lab panel the way A1C or LDL does. The CDCES's Assessment-domain skills, health history, mental-health wellbeing, and self-care considerations, are what surface depression, sexual dysfunction, sleep-apnea symptoms, or dental complaints that a person would not otherwise report, and the Care and Education Interventions domain is where the resulting referral, medication adjustment, or education plan gets built. A comprehensive visit that measures only A1C and reviews retinopathy, nephropathy, and neuropathy screening dates, without asking about mood, sleep, sexual function, and dental care, misses roughly half of this task area's tested content.